Filter by: patients
Home > Community Treatment Reports and Side Effects > Certolizumb pegol Treatment Report
What is Certolizumb pegol?

Certolizumab pegol is an antirheumatic and gastrointestinal agent used for the treatment of active Crohn's disease in patients who have inadequate response to conventional therapy; moderate to severe active rheumatoid arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
RA (Rheumatoid Arthritis) 11 4 Efficacy_major Efficacy_cant_tell
Crohn's Disease 3 1 Efficacy_major
Participate in clinical trial 1 0
Rheumatoid Arthritis 1 1 Efficacy_moderate
Systemic Onset Juvenile Arthritis 1 0

See all 22 patients currently taking Certolizumb pegol

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 4
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with Certolizumb pegol

Depressed mood 1
Fatigue 1
Anxious mood 1
None 1
Injection site reaction 1
Injection site pain 1

Reported Dosages

  2 other every other week 200 mg monthly 400 mg monthly 200 mL every other week 200 mg every other week 400 mg every other week
  1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 1 Number of Patients: 1 12 Number of Patients: 12 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking Certolizumb pegol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 67%
Doctor's advice 1   Doctor's advice: 33%
Side effects too severe 1   Side effects too severe: 33%

See all 3 patients who’ve stopped taking Certolizumb pegol

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Certolizumb pegol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Certolizumb pegol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Certolizumb pegol

Always
 5 83%
Usually
 1 17%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Certolizumb pegol

Very
 0 0%
Somewhat
 0 0%
A little
 2 33%
Not at all
 4 67%

Cost

Paid out of pocket

Cost of Certolizumb pegol

$200+
 0 0%
$100-199
 0 0%
$50-99
 2 40%
$25-49
 2 40%
< $25
 1 20%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.